Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (64)	5/26/1998 11:32:00 PM
From: Scott H. Davis	Respond to of 626

OK, I'm ready to seriously consider TTNP now. I've read what releases I could, and have several questions. I'll do more research and try to answer some myself, but if I could impose a little, If anyone can answer a few, it would be a big help. 1. Does this company have a base technology platform that they can leverage for multiple indications? For example, VICL with gene therapies, ISIP with antisense, LGND RIBI... do. Is there one or more core technologies with TTNP? 2. What about their pipline. I saw one reference to a cancer med in pre-clinical development, there are the three vaccines with recent very positive pI/II results (are there others in triels or with an IND?) Any ideas when TTNP is likely to have anything ready for an NDA (obviously assuming supportive data) 3. I read about the Nov. partnering with ILoperidone. Are other items partnered yet? plans to? I understand the corporate stratedgy with VICL (partner the vaccines, develop the meds solo). Is there an overall TTNP corporate stratedgy? 4. The yearly and qtrly filings are confusing to someone without a background in this company. I see references to Ingenex, Ansan, Geneic Sciences, ProNeura, and Trilex, but not any material explaination. Is this company a wheeler/deeler, did they grow from a fusion of several? What was the history (I've ordered the annual report, but who knows what it will contain and when I'll get one) technically, TTNP had a breakout above the declining trendline on good volume, on a bad NASDAQ day. Any info will be greatly appreciated. Noticed several names associated with LGND. Anybody(s) care to comment on the relative merit and risk/reward comparison between these two (yes, I know LGND has several probable NDAs this year) But how do these compare at current price points? (I'm not going to ask HN that question) Scott BTW, Its good to see your name associated with this thread Miljenko!